MedTrace Logo

Efficacy of a Spirulina Supplement for Amelioration of Benign ThYroid Nodules

NCT03535974 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2020-05-19

Study results available
· View outcomes & findings →

Summary

Clinical trial with a double-blind, placebo-controlled, crossover design; enrolls approximately 30 euthyroid patients with benign thyroid nodules, who will receive for 6 weeks a spirulina-based supplement, and for another 6 weeks placebo. Thyroid ecography will be performed three times for each patient, and blood tests including TSH, free T4, free T3 and ceruloplasmin/Copper will also be performed 3 times for each patient. It is expected that a decrease in the thyroid nodules occurs with the supplement administration. Compared with placebo there will be a decrease of at least 20% in the volume or the largest diameter of the nodules during the 6-week administration of the supplement.

Conditions

  • Benign Thyroid Nodule

Interventions

DIETARY_SUPPLEMENT

Preparation with Spirulina

Preparation with Spirulina to ameliorate the size of benign thyroid nodules

DIETARY_SUPPLEMENT

Placebo

Placebo administration for 6 weeks bid

Sponsors & Collaborators

  • Fundatia Bio-Forum

    lead OTHER

Principal Investigators

  • Corin Badiu, M.D. · Institutul Parhon

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-15
Primary Completion
2018-12-20
Completion
2018-12-21

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03535974 on ClinicalTrials.gov